PHARM-AD
Timeline
28 events since 2009Board
Filings
Financial
Establishments
Other
201020122014201620182020202220242026
Deadline for the 2026 accounts: 31-01-2027
2026
Assemblee Generale - Annee ComptableGeneral meeting of 04-05-20261 point ▸
- General meeting, 04-05-2026
- The deed holds 1 more point.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0819236165
Annual accounts 2025 filed PDFmicro format · 1 day before the deadline
2025
Annual accounts 2024 filed PDFmicro format · 1 day before the deadline
2024
Highest result from 2010 to 2025 net €179,337 ▲123% The operating result of €261,604 and the net result of €179,337 are both a record.
Annual accounts 2023 filed PDFmicro format · 7 days before the deadline
Change of role: Andréa LOHÉE, from manager to directorAppointment: Daniel LASANOW (director) · General meeting of 27-12-20235 points ▸
- General meeting, 27-12-2023
- 100 shares
- Director resignation, Andréa LOHÉE (manager)
- Director appointment, Andréa LOHÉE (director (not named in the articles))
- Director appointment, Daniel LASANOW (director (not named in the articles))
- The deed holds 6 more points.
2022
Annual accounts 2022 filed PDFmicro format · 32 days before the deadline
Annual accounts 2021 filed PDFmicro format · 7 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 10 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 7 days before the deadline
2019
Equity above €200,000 equity €218,390 ▲14% With a profit in every financial year since 2010, equity grows to €218,390.
Annual accounts 2018 filed PDFmicro format · 20 days before the deadline
2017
Annual accounts 2017 filed PDFmicro format · 48 days before the deadline
Equity above €150,000 equity €162,978 ▲19.5% With a profit in every financial year since 2010, equity grows to €162,978.
2016
Annual accounts 2016 filed PDFfull format · 50 days before the deadline
2015
Annual accounts 2015 filed PDFfull format · 58 days before the deadline
Liquidity more than triples current ratio 10.73 The current ratio rises from 3.19 to 10.73. Short-term debt falls from €37,394 to €10,380.
Equity above €100,000 equity €111,817 ▲17.4% With a profit in every financial year since 2010, equity grows to €111,817.
2014
Annual accounts 2014 filed PDFfull format · 43 days before the deadline
Weakest financial year net €5,063 ▼87.2% The net result drops to €5,063, the lowest from 2010 to 2025. It recovers the following year.
2013
Annual accounts 2013 filed PDFfull format · 57 days before the deadline
2012
Annual accounts 2012 filed PDFfull format · 52 days before the deadline
Liquidity more than quadruples current ratio 5.03 The current ratio rises from 1.23 to 5.03. Short-term debt falls from €43,235 to €10,652.
2011
Annual accounts 2011 filed PDFfull format · 49 days before the deadline
2010
Annual accounts 2010 filed PDFfull format · 35 days before the deadline
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank